Evidence map›Paper›PMID 40105344›Full record

ArticleJournal of clinical microbiology2025

Nanopore sequencing for precise detection of

Shanshan Yu, Ning Liu, Zhouhua Xie, Yi Zeng, Hua Wang, Qian Wang, Peibo Li, Haoran Li, Jinhao Sun, Qingdong Zhu and 7 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shanshan Yu *Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University, Beijing, China.ORCID 0000-0001-8456-5073
Ning Liu *Hebei Chest Hospital, Hebei, China.
Zhouhua Xie *The Fourth People's Hospital of Nanning, Nanning, China.
Yi Zeng *The Second Hospital of Nanjing, Nanjing, China.
Hua Wang *Anhui Chest Hospital, Hefei, China.
Qian Wang *Hangzhou Shengting Medical Technology Co., Ltd, Hangzhou, China.ORCID 0000-0001-9663-0741
Peibo Li *Chongqing Public Health Medical Center, Chongqing, China.
Haoran Li *Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Jinhao SunHebei Chest Hospital, Hebei, China.
Qingdong ZhuThe Fourth People's Hospital of Nanning, Nanning, China.
Weiwei GaoThe Second Hospital of Nanjing, Nanjing, China.
Hongcang GuAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, China.
Fuyou LiuHangzhou Shengting Medical Technology Co., Ltd, Hangzhou, China.
Peisong XuHangzhou Shengting Medical Technology Co., Ltd, Hangzhou, China.
Yunfei WangHangzhou Shengting Medical Technology Co., Ltd, Hangzhou, China.ORCID 0009-0000-4928-6853
Liang LiDepartment of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University, Beijing, China.ORCID 0000-0001-5212-5890
Yu PangDepartment of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University, Beijing, China.ORCID 0000-0001-6803-9807

Funding

Beijing Hospital Authority Ascent Plan DFL20221401| Beijing Nova Program 20220484169 & 20230484295The Capital's Funds for Health Improvement and Research 2024-1-1041
6 · The paper itself

Abstract

Tuberculosis (TB) management in endemic regions often grapples with resource constraints, including the scarcity of

Indexed as

Antitubercular AgentsDrug Resistance, BacterialMycobacterium tuberculosisNanopore SequencingTuberculosisTuberculosis, Multidrug-ResistantAdolescentAdultAgedAged, 80 and overChildChinaFemaleHumansMaleMicrobial Sensitivity TestsAntitubercular Agentsdiagnosisdrug resistancenanopore sequencingtuberculosis

Identifiers

PMID40105344
PMCPMC11980377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.